Search for: "Novo Nordisk A/S" Results 81 - 100 of 305
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Apr 2012, 7:57 am by Ronald Mann
Novo Nordisk, the Federal Circuit got a unanimous affirmance Wednesday in Kappos v. [read post]
17 Oct 2018, 8:16 am by Lindsay Offutt
It quotes a 2016 Novo Nordisk blog post to explain the manufacturer’s excuse for increased list prices: [T]he rebates, discounts and price concessions got steeper, we were losing considerable revenue – revenue we use for R&D, sales and marketing, education, disease awareness activities and medical information support. [read post]
12 Nov 2008, 7:51 am
With so much going on in China, and only a limited amount of bandwidth, I have created this weekly post to highlight articles that I feel are (1) important, (2) relevant, and (3) interesting. [read post]
17 Apr 2012, 8:57 am by Dennis Crouch
Novo Nordisk A/S, (Supreme Court 2012) This decision only slightly shifts balance of power in the pharmaceutical industry away from patentees toward generic manufacturers. [read post]
24 Dec 2007, 1:36 pm
"Mike Huckabee's $35,000 in speaking fees from stem cell researcher Novo Nordisk is getting attention. [read post]
23 Dec 2007, 5:40 am
"In addition to the payments from Novo Nordisk, Mike Huckabee took a third of a million , much of it from organizations with governmental interests, even while he was Governor of Arkansas. . . . [read post]
7 Nov 2023, 7:56 am
[T]he manufacturer of Ozempic, Novo Nordisk, said ileus [intestinal blockage] was only reported after its 'post-marketing setting,' suggesting the drugmaker only became aware of the problem after the drug was released.... [read post]
17 Apr 2012, 9:35 am by Orin Kerr
Novo Nordisk has an interesting passage about how context changes meaning. [read post]
15 Apr 2010, 5:20 am by Lawrence B. Ebert
Novo Nordisk didcome out the winner, but one sees a lot of disagreement here.On statutory construction:Statutory construction “begins with ‘the language of the statute. [read post]
16 Mar 2012, 4:32 pm by Aaron Barkoff
  I'll be part of a panel discussion entitled, "Of Labels, Patents and Use Codes: The Significance and Possible Repercussions of Novo Nordisk v. [read post]
2 May 2011, 1:12 pm by Tom Lamb
Novo Nordisk has a relatively new diabetes drug, Victoza (approved by FDA in 2010), which is in the same class of drugs as Byetta. [read post]
27 Apr 2010, 9:59 pm by Patent Docs
But the statutory language at issue involved the 2003 Medicare Prescription Drug Improvement and Modernization Act, which amended the 1984 Drug Price Competition and Patent Term Restoration Act (colloquially known as the Hatch-Waxman Act), thus raising the opinion's significance. [read post]
9 Jul 2020, 9:07 pm by Unknown
”Biopharmaceutical companies and foundations supporting the fund are:Almirall, Amgen, Bayer, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Eisai, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, LEO Pharma, Lundbeck, Menarini, Merck, MSD, Novartis, Novo Nordisk, Novo Nordisk Foundation, Pfizer, Roche, Shionogi, Takeda, Teva, and UCBFor more details on the AMR Action Fund, visit www.AMRActionFund.com. [read post]
14 Nov 2023, 9:10 am by Seeger Weiss
Seeger Weiss attorneys Chris Seeger, David Buchanan and Steven Daroci filed a lawsuit on behalf of Arlington County, Virginia against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi, and pharmacy benefit managers (PBMs) CVS Caremark, Express Scripts and OptumRx, for their alleged role in a scheme to aggressively inflate the price of insulin and other diabetes medications. [read post]
6 Jun 2023, 7:50 am by Tom Lamb
Generally, the legal basis for an Ozempic gallbladder injury case against the responsible drug company is that Novo Nordisk failed to warn doctors and patients about the risks of gallbladder diseases in a timely manner. [read post]